Je was op zoek naar: snri (Deens - Engels)

ssri eller snri
ssris or snris

behandlingsskift fra ssri/snri-antidepressiva til agomelatin
switching therapy from ssri/snri antidepressant to agomelatine

snri, ssri’ er, tricyklisk medicin eller medicin med lithium
do not start or stop taking any medicines, including those bought without a prescription, natural and herbal remedies, before checking with your doctor or pharmacist.

patienter kan opleve seponeringssymptomer efter behandlingsstop med et ssri/snri-antidepressivum.
patients may experience discontinuation symptoms after cessation from an ssri/ snri antidepressant.

i re-ly-studiet øgede ssri og snri risikoen for blødning i alle behandlingsarmene.
ssris and snris increased the risk of bleeding in re-ly in all treatment groups.

risikoen for seponeringssymptomer set for ssri og snri kan afhænge af flere faktorer blandt andet behandlingsvarigheden, dosis og hvor hurtigt dosis reduceres.
the risk of withdrawal symptoms seen with ssri’s and snri’s may be dependent on several factors including the duration and dose of therapy and the rate of dose reduction.

xeristar og placebo.risikoen for seponeringssymptomer set for ssri og snri kan afhænge af flere faktorer blandt andet behandlingsvarigheden, dosis og hvor hurtigt dosis reduceres.
the risk of withdrawal symptoms seen with ssri 's and snri 's may be dependent on several factors including the duration and dose of therapy and the rate of dose reduction.

det aktive stof i yentreve er duloxetin, der hæmmer genoptagelsen af serotonin-noradrenalin (snri).
the active substance in yentreve, duloxetine, is a serotonin-noradrenaline re-uptake inhibitor (snri).

generelt for ssri- og snri-hæmmere er disse symptomer lette til moderate og selvbegrænsende, selvom de hos nogle patienter kan være svære og/eller vedvare i længere tid.
generally, for ssris and snris, these events are mild to moderate and self-limiting, however, in some patients they may be severe and/or prolonged.